{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:40:31Z","timestamp":1787236831926,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:00:00Z","timestamp":1205193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/ncpendmet0789","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T13:33:17Z","timestamp":1205242397000},"page":"294-300","source":"Crossref","is-referenced-by-count":13,"title":["Assessment, diagnosis and treatment of a patient with hirsutism"],"prefix":"10.1038","volume":"4","author":[{"given":"Bulent O","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,11]]},"reference":[{"key":"BFncpendmet0789_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.69.809.186","volume":"69","author":"N Sonino","year":"1993","unstructured":"Sonino N  et al. (1993) Quality of life of hirsute women. Postgrad Med J 69: 186\u2013189","journal-title":"Postgrad Med J"},{"key":"BFncpendmet0789_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","volume":"20","author":"BO Yildiz","year":"2006","unstructured":"Yildiz BO (2006) Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 20: 167\u2013176","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BFncpendmet0789_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R  et al. (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89: 453\u2013462","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0789_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(96)07252-2","volume":"349","author":"RS Rittmaster","year":"1997","unstructured":"Rittmaster RS (1997) Hirsutism. Lancet 349: 191\u2013195","journal-title":"Lancet"},{"key":"BFncpendmet0789_CR5","first-page":"209","volume":"50","author":"JA Ewing","year":"1978","unstructured":"Ewing JA  et al. (1978) Hirsutism, race and testosterone levels: comparison of East Asians and Euroamericans. Hum Biol 50: 209\u2013215","journal-title":"Hum Biol"},{"key":"BFncpendmet0789_CR6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"Hatch R  et al. (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140: 815\u2013830","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpendmet0789_CR7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-59745-310-3_17","volume-title":"Contemporary Endocrinology: Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment","author":"BO Yildiz","year":"2007","unstructured":"Yildiz BO (2007) Hormonal and biochemical evaluation of polycystic ovary syndrome. In Contemporary Endocrinology: Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment, 241\u2013248 (Eds Nestler JE  et al.) Totowa, NJ: Humana Press"},{"key":"BFncpendmet0789_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W  et al. (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92: 405\u2013413","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0789_CR9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.fertnstert.2006.03.037","volume":"86","author":"RS Legro","year":"2006","unstructured":"Legro RS  et al. (2006) The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86: 914\u2013933","journal-title":"Fertil Steril"},{"key":"BFncpendmet0789_CR10","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadzki","year":"1992","unstructured":"Zawadzki JK  et al. (1992) Diagnostic criteria for polycystic ovary syndrome. In Polycystic ovary syndrome, 377\u2013384 ( Eds Dunaif A  et al.) Boston, MA: Blackwell Scientific Publications"},{"key":"BFncpendmet0789_CR11","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"BFncpendmet0789_CR12","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R  et al. (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237\u20134245","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0789_CR13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.13.10.1295","volume":"13","author":"BO Yildiz","year":"2004","unstructured":"Yildiz BO (2004) Recent advances in the treatment of polycystic ovary syndrome. Expert Opin Investig Drugs 13: 1295\u20131305","journal-title":"Expert Opin Investig Drugs"},{"key":"BFncpendmet0789_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/13543784.11.3.357","volume":"11","author":"E Carmina","year":"2002","unstructured":"Carmina E (2002) Anti-androgens for the treatment of hirsutism. Expert Opin Investig Drugs 11: 357\u2013363","journal-title":"Expert Opin Investig Drugs"},{"key":"BFncpendmet0789_CR15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","volume":"22","author":"MF Costello","year":"2007","unstructured":"Costello MF  et al. (2007) Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. Hum Reprod 22: 1200\u20131209","journal-title":"Hum Reprod"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0789","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:55:36Z","timestamp":1684425336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BFncpendmet0789"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0789","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,11]]}}}